Register For Our Mailing List

Register to receive our free weekly newsletter including editorials.

Home / 372

A game plan for managing volatility in global equities

The unfortunate reality is that we are in the late stages of an incredibly long bull market in equities, but changes to the ‘growth’ component of a global equity allocation may prove appropriate for investors.

Four types of global equities

Traditionally, Australian investors have achieved growth exposure in their global portfolios by allocating to three buckets of global equities:

1. large cap growth
2. emerging markets
3. global small caps.

It’s not hard to see why. For the better part of the last decade, we have seen large companies - like the FAANG stocks – proving generally to be stellar performers, while emerging markets and global small caps have also performed well for many years.

However, no one was fully prepared for how the COVID-19 pandemic exposed the multitude of risks in global markets.

For those investors who were contemplating changes in global equity portfolios earlier this year but did not act, the recent rally could present a timely opportunity to make some changes to sub-allocations within global equities.

This is where we believe global small and mid-cap (SMID) stocks play an important growth role in diversified portfolios.

Investors have previously not been as aware of this fourth type of asset class as of others. A lack of analyst coverage and investor attention to global SMID stocks has meant that investors have been missing out on an asset class that exhibits strong potential growth opportunity, lower valuation risk than other growth assets and diversification opportunities.

They may not be named brands, like Apple, Facebook, or Google, but what these stocks do offer is an opportunity for investors to access them during their ‘sweet spot’ of the business cycle.

So is it too late to enter the global SMID space for investors?

Allocating to global SMID equities

Global SMID companies can improve the risk-return profile by playing a growth role in investor portfolios over the medium term. They have less valuation risk than large cap growth, less absolute risk than emerging markets and less liquidity risk than small caps alone.

Further, global SMID companies have the best mix of upside and downside capture over 20 years when compared to other global market indices, as shown in Exhibit 1 below. This is an important metric when comparing returns and offers one way to measure expected performance during both market rallies and declines.

An upside capture ratio of greater than 100 indicates historical outperformance of the market during periods of positive returns (the MSCI World SMID Cap Index at 112.50), and a number less than 100 indicates relative underperformance.

Similarly, a downside capture ratio of greater than 100 would indicate a historical decline greater than the broader market during periods of stress, and a downside capture ratio of less than 100 (the MSCI World SMID Cap Index at 99.18), indicates that it historically has protected capital and declined less than the broader market during these negative periods.

Exhibit 1: Upside and Downside Capture (20 years)

Source: eVestment. MSCI Median is the median of the five indices shown in the chart. Period is for 20 years ending June 2020, run on a monthly basis. All results are in AUD terms and measured against MSCI World-ND. 

The remarkable rebound in global equities following the dramatic losses in the first quarter of 2020 has caused many investors to question whether they have ‘missed the boat’ when it comes to investing in global stocks.

The simple answer is no. We believe the current environment makes a good case for an allocation to global SMID stocks.

Valuations have lagged but fundamentals are strong

When we look at global equities as a whole, valuations are not that high, considering the MSCI World Index as a proxy. The current forward price-to-earnings ratio (P/E) is about 20x earnings, or in other words, an earnings yield of about 5%. In the context of a 0% interest rate environment, a 5% earnings yield is reasonable. But within these valuations there is massive dispersion, particularly between large cap growth stocks and value stocks.

Within the global SMID space, there is far less dispersion. As much as stocks have been rebounded off their lows, global SMID stocks have effectively gone sideways over the last three years, lagging the MSCI World Index by 4.2% per annum. As an asset class, they are almost back to where they were in Q3 2017.

In terms of valuations, the MSCI World SMID Cap Index is currently trading on a 2020 P/E of 23.1x, compared to 30.5x for MSCI World Growth Index. As another ‘growth proxy’ in global equity markets, we would argue that a 24% valuation discount is compelling. The absolute P/E of 23.1 might not sound overly cheap in an absolute sense but 2020 earnings will be well below 2019 levels.

We also think investors should acknowledge how valuations have changed over the past five years. Global SMID stocks are currently trading at a 12% premium to the broader market which is in line with its 5-year average. Global large cap growth stocks on the other hand are trading on a 43% premium to the broader market versus its 5-year average of 23%.

This discounted valuation is an attractive proposition for investors seeking diversification potential compared to large cap stocks. 

And while these stocks are not predicted to grow much this year, once we come out of the other side of COVID-19, the organic growth drivers of SMID stocks should come back. The combination of corporate cost-cutting, COVID-19-related stimulus and the reopening of global economies, positions global SMID companies for a strong rebound over the next two to three years.

Companies poised to win in a COVID-19 world

While many industries are suffering because of the COVID-19 pandemic, others have thrived in this environment, especially in the healthcare and consumer discretionary spaces.

The healthcare sector continues to boom, particularly towards research and development in pharmaceuticals and biotech industries. We believe dental orthodontics, which saw a negative impact in the short-term due to lockdowns, will present excellent earnings leverage in 2021.

Stocks that we are watching in the healthcare space include Align Technologies, Idexx Laboratories, and Danish medical devices maker Ambu.

Likewise, consumer discretionary has seen increased demand during COVID-19 as consumer behaviour changes materially. Opportunities include sectors such as home improvements, localised vacations and outdoor activities. However, overseas travel and the hospitality industry will continue to struggle.

Consumer discretionary stocks that we believe are poised to win include Tractor Supply, Pool Corp, O’Reilly Automotive, and YETI Holdings.

For investors looking to diversify their global large cap exposure, global SMID equities present investors with some strong opportunities in names we believe will do well over three to five years and beyond.

 

Ned Bell is Chief Investment Officer and Portfolio Manager at Bell Asset Management, a Channel Capital partner. Channel Capital is a sponsor of Firstlinks. This information is not advice or a recommendation in relation to purchasing or selling particular assets. It does not take into account particular investment objectives or needs.

For more articles and papers from Channel Capital and partners, click here.

 

RELATED ARTICLES

Six COVID opportunist stocks prospering in adversity

What’s the outlook for global small companies?

Why caution is needed in Aussie small companies

banner

Most viewed in recent weeks

Lessons when a fund manager of the year is down 25%

Every successful fund manager suffers periods of underperformance, and investors who jump from fund to fund chasing results are likely to do badly. Selecting a manager is a long-term decision but what else?

2022 election survey results: disillusion and disappointment

In almost 1,000 responses, our readers differ in voting intentions versus polling of the general population, but they have little doubt who will win and there is widespread disappointment with our politics.

Now you can earn 5% on bonds but stay with quality

Conservative investors who want the greater capital security of bonds can now lock in 5% but they should stay at the higher end of credit quality. Rises in rates and defaults mean it's not as easy as it looks.

30 ETFs in one ecosystem but is there a favourite?

In the last decade, ETFs have become a mainstay of many portfolios, with broad market access to most asset types, as well as a wide array of sectors and themes. Is there a favourite of a CEO who oversees 30 funds?

Betting markets as election predictors

Believe it or not, betting agencies are in the business of making money, not predicting outcomes. Is there anything we can learn from the current odds on the election results?

Meg on SMSFs – More on future-proofing your fund

Single-member SMSFs face challenges where the eventual beneficiaries (or support team in the event of incapacity) will be the member’s adult children. Even worse, what happens if one or more of the children live overseas?

Latest Updates

Superannuation

'It’s your money' schemes transfer super from young to old

Policy proposals allow young people to access their super for a home bought from older people who put the money back into super. It helps some first buyers into a home earlier but it may push up prices.

Investment strategies

Rising recession risk and what it means for your portfolio

In this environment, safe-haven assets like Government bonds act as a diversifier given the uncorrelated nature to equities during periods of risk-off, while offering a yield above term deposit rates.

Investment strategies

‘Multidiscipline’: the secret of Bezos' and Buffett’s wild success

A key attribute of great investors is the ability to abstract away the specifics of a particular domain, leaving only the important underlying principles upon which great investments can be made.

Superannuation

Keep mandatory super pension drawdowns halved

The Transfer Balance Cap limits the tax concessions available in super pension funds, removing the need for large, compulsory drawdowns. Plus there are no requirements to draw money out of an accumulation fund.

Shares

Confession season is upon us: What’s next for equity markets

Companies tend to pre-position weak results ahead of 30 June, leading to earnings downgrades. The next two months will be critical for investors as a shift from ‘great expectations’ to ‘clear explanations’ gets underway.

Economy

Australia, the Lucky Country again?

We may have been extremely unlucky with the unforgiving weather plaguing the East Coast of Australia this year. However, on the economic front we are by many measures in a strong position relative to the rest of the world.

Exchange traded products

LIC discounts widening with the market sell-off

Discounts on LICs and LITs vary with market conditions, and many prominent managers have seen the value of their assets fall as well as discount widen. There may be opportunities for gains if discounts narrow.

Sponsors

Alliances

© 2022 Morningstar, Inc. All rights reserved.

Disclaimer
The data, research and opinions provided here are for information purposes; are not an offer to buy or sell a security; and are not warranted to be correct, complete or accurate. Morningstar, its affiliates, and third-party content providers are not responsible for any investment decisions, damages or losses resulting from, or related to, the data and analyses or their use. Any general advice or ‘regulated financial advice’ under New Zealand law has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Ltd, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. For more information refer to our Financial Services Guide (AU) and Financial Advice Provider Disclosure Statement (NZ). You should consider the advice in light of these matters and if applicable, the relevant Product Disclosure Statement before making any decision to invest. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your situation, contact a professional financial adviser. Articles are current as at date of publication.
This website contains information and opinions provided by third parties. Inclusion of this information does not necessarily represent Morningstar’s positions, strategies or opinions and should not be considered an endorsement by Morningstar.

Website Development by Master Publisher.